Cadrenal Therapeutics (CVKD) vs GRI Bio (GRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
GRI Bio is the larger company by market cap ($3.8 million vs $3.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVKD | GRI |
|---|---|---|
| Share price | $0.9356 | $1.74 |
| Market cap | $3.34M | $3.80M |
| 1-day change | +0.62% | +3.57% |
| EPS (TTM) | $-4.91 | $-14.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.50 | $64.12 |
| 52-week low | $0.85 | $1.36 |
| Distance from 52-week high | -93.55% | -97.29% |
| Analyst consensus | none | none |
| Avg. price target upside | +1396.37% | +963.22% |
| Average volume | 458.82K | 328.24K |
| Shares outstanding | 3.57M | 2.19M |
| Employees | 5 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cadrenal Therapeutics
CVKD stock →Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
About GRI Bio
GRI stock →GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
CVKD vs GRI FAQ
Which is bigger, Cadrenal Therapeutics or GRI Bio?
GRI Bio (GRI) is larger, with a market capitalization of $3.80M compared with $3.34M for Cadrenal Therapeutics (CVKD).
Are Cadrenal Therapeutics and GRI Bio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.